Go Pro

Lixte Biotechnology (NMAD) Institutional Ownership

Lixte Biotechnology logo
$4.03 +0.38 (+10.41%)
As of 09/4/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:NMAD)

Current
Institutional Ownership
Percentage
5.10%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$5.96M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$44.52K
Get NMAD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NMAD Institutional Buying and Selling by Quarter

Lixte Biotechnology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/22/2026 Legacy Wealth Managment LLC ID600,669$4.46M2.0%N/A3.731%
8/18/2026 Equitable Holdings Inc.10,000$74K0.0%N/A0.053%
8/7/2026 BlackRock Inc.75,958$564K0.0%N/A0.506%
7/8/2026 FNY Investment Advisers LLC44,566$330K0.1%N/A0.297%
5/14/2026 Renaissance Technologies LLC93,000$286K0.0%-13.5%0.800%
2/19/2026 Axxcess Wealth Management LLC13,771$54K0.0%N/A0.184%
2/18/2026 XTX Topco Ltd14,545$57K0.0%N/A0.195%
2/12/2026 Federation des caisses Desjardins du Quebec93,380$367K0.0%+83.6%1.249%
2/12/2026 DRW Securities LLC54,126$213K0.0%+11.6%0.724%
2/12/2026 Renaissance Technologies LLC107,500$422K0.0%+47.0%1.438%
2/9/2026 Geode Capital Management LLC52,163$205K0.0%+25.9%0.698%
2/6/2026 Axxcess Wealth Management LLC13,771$54K0.0%N/A0.184%
4/17/2025FNY Investment Advisers LLC107,000$129K0.1%+172.8%3.396%
2/11/2025TIAA Trust National Association101,834$207K0.0%N/A4.526%
1/31/2025Atlas Legacy Advisors LLC12,707$26K0.0%N/A0.565%
1/13/2025FNY Investment Advisers LLC39,219$82K0.0%-45.3%1.744%
6/5/2023EP Wealth Advisors LLC2,211$786K0.0%N/A0.013%
2/9/2023Ethos Financial Group LLC248,084$126K0.0%N/A1.490%
8/12/2022Almanack Investment Partners LLC.248,084$185K0.0%-66.7%1.490%


NMAD Institutional Ownership - Frequently Asked Questions

During the previous two years, 12 institutional investors and hedge funds held shares of Lixte Biotechnology. The most heavily invested institutionals were Legacy Wealth Managment LLC ID ($4.46M), BlackRock Inc. ($564K), Federation des caisses Desjardins du Quebec ($367K), FNY Investment Advisers LLC ($330K), Renaissance Technologies LLC ($286K), DRW Securities LLC ($213K), and TIAA Trust National Association ($207K).Learn more on Lixte Biotechnology's institutional investors.

5.10% of Lixte Biotechnology's stock is owned by institutional investors. Learn more on NMAD's institutional investor holdings.

Of the 12 institutional investors that purchased Lixte Biotechnology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Legacy Wealth Managment LLC ID ($600.67K), FNY Investment Advisers LLC ($112.35K), TIAA Trust National Association ($101.83K), BlackRock Inc. ($75.96K), Federation des caisses Desjardins du Quebec ($42.53K), Renaissance Technologies LLC ($34.35K), and Axxcess Wealth Management LLC ($27.54K).

Institutional investors have bought a total of 866,527 shares in the last 24 months. This purchase volume represents approximately $5.96M in transactions.

The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: Renaissance Technologies LLC ($14.50K).

Institutional investors have sold a total of 14,500 shares in the last 24 months. This volume of shares sold represents approximately $44.52K in transactions.



Institutional ownership data for NASDAQ:NMAD is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/22/2026. New 13F filings are added each quarter as they're published.
From Our Partners